A photo of Esi Morgan.

Clinical Director, Division of Rheumatology

Associate Professor, UC Department of Pediatrics

513-803-2672

Board Certified

My Biography & Research

Biography

Being a doctor combines my passion for working with people and problem solving. As a rheumatologist, I take care of patients with autoimmune and autoinflammatory syndromes and musculoskeletal pain. I see patients with arthritis (JIA), dermatomyositis (muscle inflammation), lupus and other rheumatic conditions.

I strongly support shared decision-making when it comes to selecting treatment options. I take time to talk with the patient and family and understand their preferences for disease management, medication and treatment choices. I believe data provides important information about the severity of a patient’s condition. Data from labs, physical exams and patient questionnaires inform my recommendations.

I understand a rheumatology diagnosis can feel overwhelming. Patients and families must sift through a lot of information as they make decisions about a care plan. We want to empower children to control their condition and achieve their life goals. We use a team approach to give patients and families the support they need. Our team includes care from doctors, nurse practitioners, nurses, social workers, pharmacists, occupational therapists, physical therapists and nutritionists.

My path to becoming a doctor started early. I’ve always been service-oriented, and I enjoy interacting with people. In school, I liked science and math. As a doctor, I get joy from partnering with families to determine a diagnosis and from supporting patients in their journey back to health.

My research focuses on improving healthcare delivery in rheumatology and studying which treatments are most effective for juvenile arthritis. I lead the Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) — a quality improvement network of more than 20 hospitals. Together, we work to learn best practices and improve patient outcomes in arthritis.

I have been invited to give presentations on a variety of topics including quality improvement in rheumatology and engaging patients in research studies.

When I’m not working, I spend time with my large family and dogs. I also enjoy traveling, cooking, learning languages and dancing.

Additional Languages

Spanish

Clinical Interests

Childhood rheumatic diseases; juvenile idiopathic arthritis; juvenile dermatomyositis; sarcoidosis

Research Interests

Patient reported outcomes measure development; quality Improvement; health services research; economic evaluations; comparative effectiveness

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Rheumatology, Lupus

Research Divisions

Rheumatology



Blog Posts

8 Misconceptions About Juvenile Idiopathic Arthritis (JIA)

BlogRare and Complex Conditions

8 Misconceptions About Juvenile Idiopathic Arthritis (JIA)

By Esi Morgan, MD7/30/2019

My Locations

My Education

MD: Washington University School of Medicine, St. Louis, MO, 1999.

Residency: Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, 2002.

Fellowship: Rheumatology, Children’s Hospital of Philadelphia, Philadelphia, PA, 2005.

MSCE: University of Pennsylvania, Center for Clinical Epidemiology & Biostatistics, Philadelphia, PA, 2005.

Certification:  Pediatrics, 2002; Pediatric Rheumatology, 2006.

My Publications

Timing matters: Real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis. Huang, B; Qiu, T; Chen, C; Zhang, Y; Seid, M; Lovell, D; Brunner, HI; Morgan, EM; PCATS, . RMD Open. 2020; 6:e001091-e001091.

Comparative Effectiveness Research using Electronic Health Records Data: Ensure Data Quality. Huang, B; Qiu, T; Chen, C; Neace, A; Zhang, Y; Yue, XM; Zahner, J; Adams, M; Seid, M; Lovell, D; et al. Sage. 2020.

Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors. Schulert, GS; Yasin, S; Carey, B; Chalk, C; Do, T; Schapiro, AH; Husami, A; Watts, A; Brunner, HI; Huggins, J; et al. Arthritis and Rheumatology. 2019; 71:1943-1954.

OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions. Toupin-April, K; Barton, JL; Fraenkel, L; Meara, A; Li, LC; Brooks, P; de Wit, M; Stacey, D; Légaré, F; Shea, B; et al. The Journal of rheumatology. 2019; 46:1409-1414.

Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop. Morgan, EM; Munro, JE; Horonjeff, J; Horgan, B; Shea, B; Feldman, BM; Clairman, H; III, BC O; Thornhill, S; Strand, V; et al. The Journal of rheumatology. 2019; 46:1006-1013.

Utility of the PROMIS Pediatric Pain Interference Scale in Juvenile Fibromyalgia. Fussner, LM; Black, WR; Lynch-Jordan, A; Morgan, EM; Ting, TV; Kashikar-Zuck, S. Journal of Pediatric Psychology. 2019; 44:436-441.

Systemwide Implementation of Patient-Reported Outcomes in Routine Clinical Care at a Children's Hospital. Gerhardt, WE; Mara, CA; Kudel, I; Morgan, EM; Schoettker, PJ; Napora, J; Britto, MT; Alessandrini, EA. The Joint Commission Journal on Quality and Patient Safety. 2018; 44:441-453.

Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ravelli, A; Consolaro, A; Horneff, G; Laxer, RM; Lovell, DJ; Wulffraat, NM; Akikusa, JD; Al-Mayouf, SM; Anton, J; Avcin, T; et al. Annals of the Rheumatic Diseases. 2018; 77:819-828.

The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases. Ringold, S; Nigrovic, PA; Feldman, BM; Tomlinson, GA; von Scheven, E; Wallace, CA; Huber, AM; Schanberg, LE; Li, SC; Weiss, PF; et al. Arthritis and Rheumatology. 2018; 70:669-678.

Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results. Favier, LA; Taylor, J; Rich, KL; Jones, KB; Vora, SS; Harris, JG; Gottlieb, BS; Robbins, L; Lai, JT; Lee, T; et al. The Journal of rheumatology. 2018; 45:690-696.